Why a bigger deal hasn't been made of the world's first approval of a Duchenne drug

If you didn’t hear the news this week that the world’s first-ever drug to treat Duchenne’s muscular dystrophy has been approved, you’re probably not alone...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.